Literature DB >> 35594490

Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.

Diane M Harper1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35594490      PMCID： PMC9470128          DOI： 10.1200/JCO.22.00609

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  22 in total

Review 1.  HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme.

Authors:  N J Polman; P J F Snijders; G G Kenter; J Berkhof; C J L M Meijer
Journal:  Prev Med       Date:  2018-12-27       Impact factor: 4.018

Review 2.  Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.

Authors:  M Saraiya; M Steben; M Watson; L Markowitz
Journal:  Prev Med       Date:  2013-02-08       Impact factor: 4.018

3.  The impact of liquid-based cytology in decreasing the incidence of cervical cancer.

Authors:  Randall K Gibb; Mark G Martens
Journal:  Rev Obstet Gynecol       Date:  2011

4.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 5.  Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention.

Authors:  Attila T Lorincz
Journal:  Acta Cytol       Date:  2016-11-03       Impact factor: 2.319

6.  Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.

Authors:  Renée Mf Ebisch; Judith van der Horst; Meyke Hermsen; L Lucia Rijstenberg; Judith Em Vedder; Johan Bulten; Remko P Bosgraaf; Viola Mj Verhoef; Daniëlle Am Heideman; Peter Jf Snijders; Chris Jlm Meijer; Folkert J van Kemenade; Leon Fag Massuger; Willem Jg Melchers; Ruud Lm Bekkers; Albert G Siebers
Journal:  Mod Pathol       Date:  2017-03-17       Impact factor: 7.842

7.  Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.

Authors:  Jesper Hansen Bonde; Helle Pedersen; Wim Quint; Lan Xu; Marc Arbyn; Ditte Møller Ejegod
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

8.  Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.

Authors:  Federica Inturrisi; Clare A Aitken; Willem J G Melchers; Adriaan J C van den Brule; Anco Molijn; John W J Hinrichs; Hubert G M Niesters; Albert G Siebers; Rob Schuurman; Daniëlle A M Heideman; Inge M C M de Kok; Ruud L M Bekkers; Folkert J van Kemenade; Johannes Berkhof
Journal:  Lancet Reg Health Eur       Date:  2021-11-09

9.  Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).

Authors:  Wieke W Kremer; Stèfanie Dick; Daniëlle A M Heideman; Renske D M Steenbergen; Maaike C G Bleeker; Harold R Verhoeve; W Marchien van Baal; Nienke van Trommel; Gemma G Kenter; Chris J L M Meijer; Johannes Berkhof
Journal:  J Clin Oncol       Date:  2022-05-05       Impact factor: 50.717

10.  Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Didem Egemen; Li C Cheung; Xiaojian Chen; Maria Demarco; Rebecca B Perkins; Walter Kinney; Nancy Poitras; Brian Befano; Alexander Locke; Richard S Guido; Amy L Wiser; Julia C Gage; Hormuzd A Katki; Nicolas Wentzensen; Philip E Castle; Mark Schiffman; Thomas S Lorey
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.